Company / Return on Equity (ROE)
SS Innovations International, Inc. Return on Equity (ROE) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-31.7%
FY2025
5-year range
-105.9% / -31.7%
FY2023-FY2025
Trend
+70.0%
vs FY2024
Sector context
#130 of 148
Health Care
What the data says
SS Innovations International, Inc. reports negative total equity of -31.7% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-31.7% in FY2025.
Improved from -105.9% to -31.7% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 148This company -31.7% Sector average -3.2%
▼
-904.7% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 70.0% year-over-year.
- Currently 28.6pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -31.7% | +70.0% |
| FY2024 | -105.9% | +0.0% |
| FY2023 | -105.9% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026